|
|
中医药基于不同信号通路治疗胃癌的研究进展
|
Abstract:
胃癌是全球常见的消化系统恶性肿瘤之一，其死亡率和发病率居高不下。近年来，中医药在胃癌治疗中展现出独特的优势和潜力。大量研究表明，中医药可通过调控多个关键信号通路，进而抑制胃癌的细胞增殖以及迁徙能力，调控上皮间质转化等，从而发挥抗肿瘤的作用。本文从MAPK、PI3K、Wnt信号通路对胃癌治疗的进展作一综述，以期为胃癌的中医药治疗提供新的思路和理论依据。
Gastric cancer is one of the most common malignant tumors of the digestive system in the world, with high mortality and morbidity. In recent years, traditional Chinese medicine (TCM) has shown unique advantages and potential in the treatment of gastric cancer. A large number of studies have shown that traditional Chinese medicine can inhibit the proliferation and migration of gastric cancer cells and regulate epithelial-mesenchymal transition by regulating multiple key signaling pathways, thus playing an anti-tumor role. This article reviews the progress of the treatment of gastric cancer from the MAPK, PI3K and Wnt signaling pathways, in order to provide new ideas and theoretical basis for the treatment of gastric cancer with traditional Chinese medicine.
| [1] | 冯金华, 刘亚江, 颜慧玲, 等. 四君子汤对胃癌肿瘤干细胞标志物活性及TFAP4蛋白的作用机制[J]. 中国老年学杂志, 2024, 44(7): 1739-1744. |
| [2] | Wang, X., Wu, W.K.K., Gao, J., Li, Z., Dong, B., Lin, X., et al. (2019) Autophagy Inhibition Enhances PD-L1 Expression in Gastric Cancer. Journal of Experimental & Clinical Cancer Research, 38, Article No. 140. https://doi.org/10.1186/s13046-019-1148-5 |
| [3] | Yang, W., Zhao, H., Yu, Y., Wang, J., Guo, L., Liu, J., et al. (2023) Updates on Global Epidemiology, Risk and Prognostic Factors of Gastric Cancer. World Journal of Gastroenterology, 29, 2452-2468. https://doi.org/10.3748/wjg.v29.i16.2452 |
| [4] | 中国抗癌协会胃癌专业委员会. 胃癌诊治难点中国专家共识(2020版) [J]. 中国实用外科杂志, 2020, 40(8): 869-904. |
| [5] | Yuan, L., Xu, Z., Ruan, S., Mo, S., Qin, J. and Cheng, X. (2020) Long Non-Coding RNAs towards Precision Medicine in Gastric Cancer: Early Diagnosis, Treatment, and Drug Resistance. Molecular Cancer, 19, Article No. 96. https://doi.org/10.1186/s12943-020-01219-0 |
| [6] | 李慧臻, 马佳乐, 杨岩, 等. 半夏泻心汤调控Notch信号通路影响MNNG诱导胃癌发生发展的作用机制研究[J]. 中华中医药学刊, 1-13. http://kns.cnki.net/kcms/detail/21.1546.r.20250205.1158.014.html, 2025-04-16. |
| [7] | 唐铮芳, 安鹏航, 魏征, 等. 中药通过调控不同信号通路治疗胃癌机制研究进展[J]. 江苏中医药, 2025, 57(1): 77-81. |
| [8] | 侯文沛, 杨燕. 中医药治疗中晚期胃癌的优势与疗效机制[J]. 现代中西医结合杂志, 2019, 28(6): 677-680. |
| [9] | 彭金婵, 谢胜, 王光耀, 等. 基于MAPK信号通路的中医药干预脓毒症的研究进展[J]. 世界科学技术-中医药现代化, 2024, 26(11): 3006-3015. |
| [10] | 许芳熙, 唐梅文, 黄乐韵, 等. 基于MAPK信号通路探究中医药治疗胃癌的作用机制及研究进展[J/OL]. 辽宁中医药大学学报: 1-17. http://kns.cnki.net/kcms/detail/21.1543.R.20250310.1345.006.html, 2025-04-16. |
| [11] | García-Hernández, L., García-Ortega, M.B., Ruiz-Alcalá, G., Carrillo, E., Marchal, J.A. and García, M.Á. (2021) The P38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer. International Journal of Molecular Sciences, 23, Article 370. https://doi.org/10.3390/ijms23010370 |
| [12] | Cargnello, M. and Roux, P.P. (2011) Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases. Microbiology and Molecular Biology Reviews, 75, 50-83. https://doi.org/10.1128/mmbr.00031-10 |
| [13] | Chen, Q., Shen, L., Chen, C., et al. (2019) Cetuximab Combined with Cisplatin Improves the Prognosis of Gastric Cancer Patients and Its Effect on P38 MAPK Expression. Journal of BUON, 24, 2490-2498. |
| [14] | Jiang, F., Li, M., Wang, H., Ding, B., Zhang, C., Ding, Z., et al. (2019) Coelonin, an Anti-Inflammation Active Component of Bletilla striata and Its Potential Mechanism. International Journal of Molecular Sciences, 20, Article 4422. https://doi.org/10.3390/ijms20184422 |
| [15] | 王尧, 周欣濠, 向利军. 白芨多糖通过p38MAPK信号通路介导miR-320a靶向调控PBX3抑制胃癌模型大鼠肿瘤细胞增殖、转移及侵袭的机制[J]. 中国老年学杂志, 2024, 44(24): 6064-6068. |
| [16] | 肖洋, 段金芳, 刘影, 等. 吴茱萸炮制方法和功能主治历史沿革[J]. 中国实验方剂学杂志, 2017, 23(3): 223-228. |
| [17] | 刘丽, 张笑敏, 许浚, 等. 吴茱萸化学成分和药理作用及质量标志物(Q-marker)的预测分析[J]. 中草药, 2020, 51(10): 2689-2702. |
| [18] | 千维娜, 李治, 方瑜, 等. 吴茱萸碱通过MAPK信号通路抑制人胃癌细胞的体外实验研究[J]. 第三军医大学学报, 2021, 43(16): 1535-1542. |
| [19] | Wu, L., Yang, Y., Mao, Z., Wu, J., Ren, D., Zhu, B., et al. (2021) Processing and Compatibility of Corydalis yanhusuo: Phytochemistry, Pharmacology, Pharmacokinetics, and Safety. Evidence-Based Complementary and Alternative Medicine, 2021, Article ID: 1271953. https://doi.org/10.1155/2021/1271953 |
| [20] | Jiang, X., Wang, J., Deng, X., Xiong, F., Ge, J., Xiang, B., et al. (2019) Role of the Tumor Microenvironment in PD-L1/PD-1-Mediated Tumor Immune Escape. Molecular Cancer, 18, Article No. 10. https://doi.org/10.1186/s12943-018-0928-4 |
| [21] | 韩超, 胡晓云, 刘畅, 等. 延胡索通过靶向CXCL17激活AMPK信号通路下调PD-L1抑制EB病毒感染诱导的胃癌免疫逃逸[J]. 中国医科大学学报, 2024, 53(5): 414-420. |
| [22] | 张鑫, 周雪冰, 高铭, 等. 虫草素通过激活AMPK和MAPK信号通路抑制脂代谢抑制人胃癌细胞的增殖和迁移[J]. 细胞与分子免疫学杂志, 2022, 38(6): 513-521. |
| [23] | 刘鑫雨, 王志强, 姚宁宁, 等. 射干苷通过PI3K/Akt/mTOR信号通路诱导胃癌HGC-27细胞凋亡和自噬[J/OL]. 中华中医药学刊: 1-15. http://kns.cnki.net/kcms/detail/21.1546.R.20250312.1452.010.html, 2025-04-16. |
| [24] | Matsuoka, T. and Yashiro, M. (2014) The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma. Cancers, 6, 1441-1463. https://doi.org/10.3390/cancers6031441 |
| [25] | Deng, S., Leong, H.C., Datta, A., Gopal, V., Kumar, A.P. and Yap, C.T. (2022) PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression. Cancers, 14, Article 1652. https://doi.org/10.3390/cancers14071652 |
| [26] | Wu, S., Chen, M., Huang, J., Zhang, F., Lv, Z., Jia, Y., et al. (2021) ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis through PI3K/Akt Signaling and MAPK-Dependent Focal Adhesion Disassembly. Cancer Research, 81, 986-1000. https://doi.org/10.1158/0008-5472.can-20-0049 |
| [27] | 王延丽, 朱西杰, 肖清燕, 等. 复方蜥蜴散治疗胃癌前病变临床研究[J]. 河南中医, 2014, 34(6): 1114-1115. |
| [28] | 李铮, 程翻娥, 刘彩月, 等. 复方蜥蜴散调控PI3K/ Akt/ MMP通路对胃癌耐药细胞增殖、迁移及侵袭的影响[J]. 中药药理与临床, 2025, 41(1): 45-51. |
| [29] | Zhu, Y.Z., Wu, W., Zhu, Q. and Liu, X. (2018) Discovery of Leonuri and Therapeutical Applications: From Bench to Bedside. Pharmacology & Therapeutics, 188, 26-35. https://doi.org/10.1016/j.pharmthera.2018.01.006 |
| [30] | 关昊, 李宗禹, 赖婧玥, 等. 益母草碱调节PI3K/Akt/GSK-3β信号通路对胃癌细胞的恶性生物学行为的影响[J]. 药物生物技术, 2024, 31(6): 619-623. |
| [31] | Hu, X., Pan, G., Luo, J., Gao, X., Mu, Y., Wang, Z., et al. (2023) Kuwanon H Inhibits Melanoma Growth through Cytotoxic Endoplasmic Reticulum Stress and Impaired Autophagy Flux. Journal of Agricultural and Food Chemistry, 71, 13768-13782. https://doi.org/10.1021/acs.jafc.3c02257 |
| [32] | Guo, C., Huang, Q., Wang, Y., Yao, Y., Li, J., Chen, J., et al. (2023) Therapeutic Application of Natural Products: NAD+ Metabolism as Potential Target. Phytomedicine, 114, Article ID: 154768. https://doi.org/10.1016/j.phymed.2023.154768 |
| [33] | 耿志军, 杨晶晶, 牛民主, 等. 桑黄酮G通过调控PI3K/AKT/mTOR通路抑制胃癌细胞的生长、迁移和侵袭[J]. 南方医科大学学报, 2024, 44(8): 1476-1484. |
| [34] | Fan, Y., Zhang, X., Tong, Y., Chen, S. and Liang, J. (2022) Curcumin against Gastrointestinal Cancer: A Review of the Pharmacological Mechanisms Underlying Its Antitumor Activity. Frontiers in Pharmacology, 13, Article 990475. https://doi.org/10.3389/fphar.2022.990475 |
| [35] | 陈海燕, 曾雪莉. 花旗松素通过PI3K/AKT/mTOR通路对宫颈癌SiHa细胞自噬、凋亡和衰老的影响[J]. 天津中医药大学学报, 2022, 41(6): 789-796. |
| [36] | 冯敏超, 陈国忠, 秦百君, 等. 靶向Wnt/β-catenin通路中医药防治胃癌的研究进展[J]. 中华中医药学刊, 2023, 41(2): 158-162. |
| [37] | 钟云峰, 肖愉洁, 夏淦, 等. 姜黄素调节PI3K/AKT/mTOR信号通路对胃癌细胞增殖、凋亡和化疗耐药性的影响[J]. 天津中医药大学学报, 2024, 43(8): 701-707. |
| [38] | 刘一帆, 席作武, 王成志, 等. 中药活性成分调控细胞线粒体凋亡抗胃癌的研究进展[J]. 药物评价研究, 2025, 48(3): 770-779. |
| [39] | Li, Y., Liu, C., Zhang, X., Huang, X., Liang, S., Xing, F., et al. (2022) CCT5 Induces Epithelial-Mesenchymal Transition to Promote Gastric Cancer Lymph Node Metastasis by Activating the Wnt/β-Catenin Signalling Pathway. British Journal of Cancer, 126, 1684-1694. https://doi.org/10.1038/s41416-022-01747-0 |
| [40] | MacDonald, B.T., Tamai, K. and He, X. (2009) Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases. Developmental Cell, 17, 9-26. https://doi.org/10.1016/j.devcel.2009.06.016 |
| [41] | Peng, Y., Zhang, X., Feng, X., Fan, X. and Jin, Z. (2016) The Crosstalk between MicroRNAs and the Wnt/β-Catenin Signaling Pathway in Cancer. Oncotarget, 8, 14089-14106. https://doi.org/10.18632/oncotarget.12923 |
| [42] | 程诚, 曾永蕾, 王茎, 等. 观察附子乌头碱对正常615小鼠外周血单核细胞前列腺素E2表达影响及对调节T细胞调节作用[J]. 辽宁中医药大学学报, 2020, 22(4): 42-46. |
| [43] | Du, J. and Xu, R. (2012) RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast Cancer. International Journal of Molecular Sciences, 13, 15755-15766. https://doi.org/10.3390/ijms131215755 |
| [44] | 黄亚琴, 么玲, 郑丽, 等. 附子提取物通过影响RORα通路表达调控胃癌细胞增殖的作用机制[J]. 中国老年学杂志, 2024, 44(15): 3778-3781. |
| [45] | 黄梦遥, 陈国忠, 郑日辉, 等. 七方胃痛颗粒对人胃癌细胞MKN-45裸鼠移植瘤生长及Wnt/β-catenin信号通路的影响[J]. 时珍国医国药, 2023, 34(12): 2861-2863. |
| [46] | 凌康, 王颢. 胃癌细胞株SGC-7901的Wnt/β-Catenin信号途径与Caspase-8、Caspase-3及Bcl-2的关系[J]. 重庆医科大学学报, 2009, 34(6): 690-693. |
| [47] | 龙丹, 毛晨晗, 刘雅璇, 等. 基于Wnt/β-catenin通路研究三物白散对胃癌AGS细胞凋亡的影响[J]. 时珍国医国药, 2023, 34(12): 2885-2889. |
| [48] | Kleist, B., Xu, L., Li, G., et al. (2011) Expression of the Adult Intestinal Stem Cell Marker LGR5 in the Metastatic Cascade of Colo-Rectal Cancer. International Journal of Clinical and Experimental Pathology, 4, 327-335. |
| [49] | 张效泽, 朱方圆, 文俊凇, 等. 南蛇藤提取物调控Lgr5/Wnt/β-catenin信号通路逆转胃癌前病变的机制[J]. 中国实验方剂学杂志, 2024, 30(12): 70-77. |
| [50] | 谷金繁, 王翔, 陈建, 等. 加味小陷胸汤干预Wnt/β-catenin信号通路抑制人胃癌MGC803细胞上皮间质转化[J]. 中国实验方剂学杂志, 2022, 28(4): 42-50. |
| [51] | Xin, P., Xu, X., Deng, C., Liu, S., Wang, Y., Zhou, X., et al. (2020) The Role of JAK/STAT Signaling Pathway and Its Inhibitors in Diseases. International Immunopharmacology, 80, Article ID: 106210. https://doi.org/10.1016/j.intimp.2020.106210 |
| [52] | 丛云苗, 商行, 常天瀛, 等. 基于JAK/STAT信号通路探讨中药治疗心血管疾病的研究进展[J]. 中国老年学杂志, 2025, 45(2): 498-503. |
| [53] | Mengie Ayele, T., Tilahun Muche, Z., Behaile Teklemariam, A., Bogale, A. and Chekol Abebe, E. (2022) Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review. Journal of Inflammation Research, 15, 1349-1364. https://doi.org/10.2147/jir.s353489 |
| [54] | Wei, W., He, J., Ruan, H., et al. (2019) In Vitro and in Vivo Cytotoxic Effects of Chrysoeriol in Human Lung Carcinoma Are Facilitated through Activation of Autophagy, Sub-G1/G0 Cell Cycle Arrest, Cell Migration and Invasion Inhibition and Modulation of MAPK/ERK Signalling Pathway. Journal of BUON, 24, 936-942. |
| [55] | Hirano, T. (2020) IL-6 in Inflammation, Autoimmunity and Cancer. International Immunology, 33, 127-148. https://doi.org/10.1093/intimm/dxaa078 |
| [56] | 刘霞, 杨东, 张朵朵, 等. 金圣草黄素抑制IL-6/JAK2/STAT3通路抑制人胃癌裸鼠原位移植瘤生长和转移[J]. 河北医学, 2024, 30(11): 1766-1772. |
| [57] | 刘兴红, 刘瑾, 陈海艳, 等. 斑螯酸钠抑制JAK2/STAT3信号通路对胃癌细胞增殖及凋亡的影响[J]. 肿瘤防治研究, 2024, 51(11): 913-917. |
| [58] | Qin, J., Chen, J., Peng, F., Sun, C., Lei, Y., Chen, G., et al. (2022) Pharmacological Activities and Pharmacokinetics of Liquiritin: A Review. Journal of Ethnopharmacology, 293, 115257. https://doi.org/10.1016/j.jep.2022.115257 |
| [59] | 兰春燕, 杨小兰, 贺雪峰, 等. 甘草苷对胃癌荷瘤小鼠免疫功能的调节作用及机制研究[J]. 中国药房, 2024, 35(15): 1862-1867. |
| [60] | Kim, E.J., Kim, S.Y., Kim, S. and Lee, M. (2017) A Novel Topoisomerase 2a Inhibitor, Cryptotanshinone, Suppresses the Growth of PC3 Cells without Apparent Cytotoxicity. Toxicology and Applied Pharmacology, 330, 84-92. https://doi.org/10.1016/j.taap.2017.07.007 |
| [61] | 曹叶芝, 张琦, 汪玲虎, 等. 隐丹参酮调节JAK2/STAT3通路抑制胃癌耐药细胞增殖[J]. 中医学报, 2024, 39(5): 1036-1044. |
| [62] | 公艳霞, 白敏, 刘自由, 等. 基于IL-6/JAK2/STAT3通路探讨化瘀消痞汤对胃癌前病变大鼠胃黏膜损伤的作用及机制[J]. 中药新药与临床药理, 2024, 35(12): 1827-1834. |
